Cargando…

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control

Detalles Bibliográficos
Autores principales:	Wu, Tc, Hung, Chien-Fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990968/ http://dx.doi.org/10.1186/2051-1426-1-S1-P78

Ejemplares similares

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
por: Zha, Yuanyuan, et al.
Publicado: (2015)

Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances the efficacy of therapeutic vaccine in cervicovaginal tumor
por: Lee, Sung-Jong, et al.
Publicado: (2015)

Lm-LLO immunotherapies targeting multiple antigens and their impact on different mechanisms in the tumor microenvironment
por: Wallecha, Anu, et al.
Publicado: (2014)

LAG-3 and 4-1BB identify dysfunctional antigen-specific T cells in the tumor microenvironment and combinatorial LAG-3/4-1BB targeting gives synergistic tumor control
por: Williams, Jason B, et al.
Publicado: (2015)

Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
por: Kosmides, Alyssa K, et al.
Publicado: (2014)

The immunological basis of tumor therapy by targeted delivery of TNFa to tumor vessels
por: Balza, Enrica, et al.
Publicado: (2006)

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

IL-15 is an inflammatory mediator in the tumor microenvironment
por: Anthony, Scott M, et al.
Publicado: (2015)

TGFβ and activin A control regulatory T cells in irradiated tumors
por: Vanpouille-Box, Claire, et al.
Publicado: (2015)

The genetic landscape of the T cell non-inflamed tumor microenvironment in human solid tumors
por: Luke, Jason J, et al.
Publicado: (2015)

A chimeric antigen receptor against prostate-specific membrane antigen, a tumor vasculature target
por: Santoro, Stephen P, et al.
Publicado: (2013)

Viral vector delivery of Env trimer immunogens
por: Parks, CL, et al.
Publicado: (2012)

Trp53 inactivation in the tumor microenvironment promotes tumor progression by enhancing pro-inflammatory tumor stromal populations
por: Guo, Gang, et al.
Publicado: (2013)

Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
por: Smith, Andressa A, et al.
Publicado: (2013)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Immunotherapy generates selective pressure for acquisition of immunogenic neoantigens in escape tumors
por: Pan, Jenny H, et al.
Publicado: (2015)

Cross-presentation of the oncofoetal tumor antigen 5T4 from irradiated prostate cancer cells - a key role for Hsp70
por: Salimu, Josephine C, et al.
Publicado: (2014)

Genome editing of tumor specific T cells for sustained functionality in a suppressive tumor microenvironment
por: Pedersen, Sara R, et al.
Publicado: (2015)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2013)

Egr2 targets identify a population of dysfunctional T cells in the tumor microenvironment with immune modulatory properties
por: Williams, Jason, et al.
Publicado: (2014)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

TIM-3(+) T cells are not exhausted but activated cells in the tumor microenvironment
por: Jie, Hyun-Bae, et al.
Publicado: (2013)

Vascular normalization: a strategy to recondition the tumor immune microenvironment
por: Huang, Yuhui, et al.
Publicado: (2013)

Vaccination with pre-diagnostic tumor antigens but not established tumor antigens inhibits spontaneous tumorigenesis in TgMMTV-neu mice
por: Stanton, Sasha E, et al.
Publicado: (2013)

Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy
por: Jiang, Hong, et al.
Publicado: (2015)

Antigen-specific T cell redirectors (ATR) for antigen-specific redirection of T cells to tumors
por: Schütz, Christian, et al.
Publicado: (2014)

Control of Tumors by Antigen-Specific CD8(+) T Cells through PDL1-Targeted Delivery of Antigenic Peptide
por: Feng, Po-Hao, et al.
Publicado: (2022)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Role of VEGF signalling in the regulation of KDR expression in endothelial and tumoral microenvironment
por: Serpa, Jacinta, et al.
Publicado: (2010)

Muci specific IGE to modify myeloid derived cells of the tumor microenvironment
por: Mollick, J, et al.
Publicado: (2013)

Intratumoral injections of G100 (synthetic TLR4 agonist) increase trafficking of lentiviral vector-induced antigen-specific CD8 T cells to the tumor microenvironment
por: Albershardt, Tina C, et al.
Publicado: (2015)

The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
por: Tsang, Kwong Y, et al.
Publicado: (2015)

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

Programming the lymph node microenvironment to enhance anti-tumor T cell immunity in neuroblastoma
por: Gammon, Joshua M, et al.
Publicado: (2015)

Enhanced Vaccine Immunogenicity Enabled by Targeted Cytosolic Delivery of Tumor Antigens into Dendritic Cells
por: Truex, Nicholas L., et al.
Publicado: (2023)

Combination immunotherapy with oncolytic vaccinia virus and checkpoint inhibitor following local tumor irradiation
por: Minev, Boris, et al.
Publicado: (2014)

Colony stimulating factors secreted by irradiated autologous tumor cell vaccines inhibit immunity
por: Ravindranathan, Sruthi, et al.
Publicado: (2015)

Targeting non-viral vectors to tumor cells and the tumor microenvironment
por: Moura, Vera, et al.
Publicado: (2010)

Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule
por: Byrd, Tiara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b0sfdg0lifla7lbnelt762g0om